Axogen Financial Statements From 2010 to 2026

AXGN Stock  USD 34.00  0.11  0.32%   
Axogen's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Axogen's valuation are provided below:
Gross Profit
160.5 M
Profit Margin
(0.01)
Market Capitalization
1.7 B
Enterprise Value Revenue
8.232
Revenue
214.7 M
We have found one hundred twenty available fundamental signals for Axogen Inc, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate Axogen's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 30th of January 2026, Market Cap is likely to grow to about 276.8 M. Also, Enterprise Value is likely to grow to about 312.9 M

Axogen Total Revenue

226.21 Million

Check Axogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.5 M, Interest Expense of 9.9 M or Total Revenue of 226.2 M, as well as many indicators such as Price To Sales Ratio of 3.33, Dividend Yield of 0.27 or PTB Ratio of 6.0. Axogen financial statements analysis is a perfect complement when working with Axogen Valuation or Volatility modules.
  
Build AI portfolio with Axogen Stock
Check out the analysis of Axogen Correlation against competitors.

Axogen Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets246 M234.3 M119.2 M
Slightly volatile
Short and Long Term Debt Total82.9 M79 M39.5 M
Slightly volatile
Other Current Liabilities24.9 M23.7 M10.1 M
Slightly volatile
Total Current Liabilities37 M35.2 M16.2 M
Slightly volatile
Property Plant And Equipment Net119.5 M113.8 M40.9 M
Slightly volatile
Cash33.3 M31.7 M25 M
Slightly volatile
Non Current Assets Total126.2 M120.2 M43.7 M
Slightly volatile
Cash And Short Term Investments20.2 M38.5 M42.2 M
Slightly volatile
Net Receivables29.1 M27.7 M13.4 M
Slightly volatile
Common Stock Shares Outstanding53.4 M50.9 M31.2 M
Slightly volatile
Liabilities And Stockholders Equity246 M234.3 M119.2 M
Slightly volatile
Non Current Liabilities Total83.6 M79.6 M38 M
Slightly volatile
Inventory40.1 M38.2 M13.9 M
Slightly volatile
Other Stockholder Equity476.6 M453.9 M235.7 M
Slightly volatile
Total Liabilities120.5 M114.8 M54.1 M
Slightly volatile
Property Plant And Equipment Gross143.5 M136.7 M46.1 M
Slightly volatile
Total Current Assets119.8 M114.1 M75.5 M
Slightly volatile
Short Term Debt1.7 M1.8 M4.5 M
Pretty Stable
Intangible Assets5.3 MM2.2 M
Slightly volatile
Other Current Assets10.2 M9.7 M4.9 M
Slightly volatile
Accounts Payable9.7 M9.2 M5.2 M
Slightly volatile
Common Stock Total Equity512 K487.6 K322.5 K
Slightly volatile
Common Stock532.5 K507.1 K326.3 K
Slightly volatile
Other Liabilities2.6 K2.7 K208.3 K
Slightly volatile
Property Plant Equipment113.1 M107.7 M38.3 M
Slightly volatile
Long Term Debt34.9 M54.6 M31.6 M
Slightly volatile
Long Term Debt Total79.8 M76 M37.7 M
Slightly volatile
Capital Surpluse210.4 M414.2 M217.3 M
Slightly volatile
Short and Long Term Debt737.9 K776.7 K9.8 M
Slightly volatile
Net Invested Capital149.3 M174.1 M103.4 M
Slightly volatile
Net Working Capital72 M61.7 M67.5 M
Slightly volatile
Capital Stock456.3 K507.1 K410.6 K
Slightly volatile
Non Current Liabilities Other44.8 K84.6 K90.1 K
Slightly volatile
Capital Lease Obligations24 M24.4 M21.5 M
Slightly volatile

Axogen Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization9.5 MMM
Slightly volatile
Interest Expense9.9 M9.4 M3.9 M
Slightly volatile
Total Revenue226.2 M215.4 M90 M
Slightly volatile
Gross Profit171.4 M163.3 M70.7 M
Slightly volatile
Other Operating Expenses230.2 M219.2 M103.1 M
Slightly volatile
Cost Of Revenue54.8 M52.2 M19.3 M
Slightly volatile
Total Operating Expenses175.4 M167.1 M83.7 M
Slightly volatile
Selling General Administrative47.1 M44.9 M22.4 M
Slightly volatile
Research Development33.5 M31.9 M14.1 M
Slightly volatile
Selling And Marketing Expenses48.7 M90.2 M44.9 M
Slightly volatile
Interest Income2.5 M2.1 M3.1 M
Slightly volatile
Reconciled Depreciation9.5 MM3.1 M
Slightly volatile

Axogen Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow44.7 M42.6 M26.9 M
Slightly volatile
Depreciation9.5 MMM
Slightly volatile
Capital Expenditures3.6 M5.2 M6.9 M
Slightly volatile
End Period Cash Flow40.5 M38.6 M28.3 M
Slightly volatile
Stock Based Compensation19.2 M18.3 M7.6 M
Slightly volatile
Change To Netincome20.2 M19.2 M9.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.333.55.0166
Very volatile
Dividend Yield0.270.260.2671
Slightly volatile
Days Sales Outstanding51.3154.0160.7686
Slightly volatile
Average Payables3.2 M3.1 MM
Slightly volatile
Stock Based Compensation To Revenue0.09280.09760.4389
Slightly volatile
Capex To Depreciation0.490.522.5924
Pretty Stable
EV To Sales3.523.75.1538
Very volatile
Inventory Turnover2.861.571.5062
Pretty Stable
Days Of Inventory On Hand173240287
Slightly volatile
Payables Turnover6.196.513.2044
Slightly volatile
Sales General And Administrative To Revenue0.360.240.3549
Slightly volatile
Average Inventory3.1 M2.9 MM
Slightly volatile
Research And Ddevelopement To Revenue0.10.130.1503
Pretty Stable
Capex To Revenue0.02060.02170.0622
Slightly volatile
Cash Per Share0.670.681.3575
Very volatile
Days Payables Outstanding84.4657.99149
Slightly volatile
Intangibles To Total Assets0.05270.03150.0253
Pretty Stable
Current Ratio2.772.926.022
Slightly volatile
Receivables Turnover6.646.996.1396
Slightly volatile
Capex Per Share0.120.0920.1749
Slightly volatile
Average ReceivablesM8.6 M6.7 M
Slightly volatile
Revenue Per Share4.03.812.3284
Slightly volatile
Interest Debt Per Share1.542.01.3629
Pretty Stable
Debt To Assets0.330.30.465
Slightly volatile
Graham Number13.4812.8413.4603
Slightly volatile
Operating Cycle242283348
Slightly volatile
Days Of Payables Outstanding84.4657.99149
Slightly volatile
Ebt Per Ebit2.862.731.5447
Slightly volatile
Long Term Debt To Capitalization0.270.280.4846
Slightly volatile
Total Debt To Capitalization0.590.460.5506
Slightly volatile
Quick Ratio1.841.945.0749
Slightly volatile
Net Income Per E B T1.211.151.0195
Slightly volatile
Cash Ratio0.770.813.0214
Slightly volatile
Cash Conversion Cycle173225222
Pretty Stable
Days Of Inventory Outstanding173240287
Slightly volatile
Days Of Sales Outstanding51.3154.0160.7686
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.00210.00221.3589
Pretty Stable
Fixed Asset Turnover1.621.715.4667
Slightly volatile
Debt Ratio0.330.30.465
Slightly volatile
Price Sales Ratio3.333.55.0166
Very volatile
Asset Turnover0.941.060.7266
Slightly volatile
Gross Profit Margin0.460.680.7199
Pretty Stable

Axogen Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap276.8 M263.6 M359.7 M
Pretty Stable
Enterprise Value312.9 M298 M379.7 M
Pretty Stable

Axogen Fundamental Market Drivers

Forward Price Earnings86.2069
Cash And Short Term Investments33.5 M

Axogen Upcoming Events

12th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Axogen Financial Statements

Axogen investors utilize fundamental indicators, such as revenue or net income, to predict how Axogen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue12.6 K12 K
Total Revenue215.4 M226.2 M
Cost Of Revenue52.2 M54.8 M
Stock Based Compensation To Revenue 0.10  0.09 
Sales General And Administrative To Revenue 0.24  0.36 
Research And Ddevelopement To Revenue 0.13  0.10 
Capex To Revenue 0.02  0.02 
Revenue Per Share 3.81  4.00 
Ebit Per Revenue(0.02)(0.02)

Pair Trading with Axogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axogen will appreciate offsetting losses from the drop in the long position's value.

Moving against Axogen Stock

  0.94OTC Ocumetics Technology CorpPairCorr
  0.79IHC Inspiration HealthcarePairCorr
  0.66300869 Contec Medical SystemsPairCorr
  0.54SNN Smith Nephew SNATSPairCorr
  0.39688139 Qingdao Haier BiomedicalPairCorr
The ability to find closely correlated positions to Axogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axogen Inc to buy it.
The correlation of Axogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:
Check out the analysis of Axogen Correlation against competitors.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Will Health Care Equipment & Supplies sector continue expanding? Could Axogen diversify its offerings? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Axogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.05)
Revenue Per Share
4.67
Quarterly Revenue Growth
0.235
Return On Assets
0.0121
Return On Equity
(0.02)
Investors evaluate Axogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Axogen's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Axogen's market price to deviate significantly from intrinsic value.
Understanding that Axogen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Axogen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Axogen's market price signifies the transaction level at which participants voluntarily complete trades.